DVA vs LEN · P/E 14, rev $12.82B vs rev $34.19B
DaVita HealthCare Partners Inc (DVA) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
LEN (LEN) common stock.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. LEN currently screens at market cap $0.
Not investment advice. Open the DVA and LEN stock pages for the full models.
Not investment advice.